SANOFI (1SAN.MI) Stock Fundamental Analysis
BIT:1SAN - Euronext Milan - FR0000120578 - Common Stock - Currency: EUR
1SAN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 51 industry peers in the Pharmaceuticals industry. While 1SAN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1SAN has a decent growth rate and is not valued too expensively. 1SAN also has an excellent dividend rating. These ratings could make 1SAN a good candidate for dividend investing.
1. Profitability
1.1 Basic Checks
1SAN had positive earnings in the past year.
1SAN had a positive operating cash flow in the past year.
1SAN had positive earnings in each of the past 5 years.
In the past 5 years 1SAN always reported a positive cash flow from operatings.
1.2 Ratios
1SAN's Return On Assets of 9.00% is fine compared to the rest of the industry. 1SAN outperforms 74.51% of its industry peers.
Looking at the Return On Equity, with a value of 15.37%, 1SAN is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 15.58%, 1SAN is in the better half of the industry, outperforming 78.43% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1SAN is significantly below the industry average of 14.91%.
The 3 year average ROIC (7.46%) for 1SAN is below the current ROIC(15.58%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9% | ||
| ROE | 15.37% | ||
| ROIC | 15.58% |
ROA(3y)5.07%
ROA(5y)6.23%
ROE(3y)8.63%
ROE(5y)10.88%
ROIC(3y)7.46%
ROIC(5y)7.05%
1.3 Margins
With a decent Profit Margin value of 12.97%, 1SAN is doing good in the industry, outperforming 62.75% of the companies in the same industry.
In the last couple of years the Profit Margin of 1SAN has grown nicely.
1SAN has a better Operating Margin (22.04%) than 60.78% of its industry peers.
In the last couple of years the Operating Margin of 1SAN has grown nicely.
1SAN has a Gross Margin (70.04%) which is in line with its industry peers.
In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.04% | ||
| PM (TTM) | 12.97% | ||
| GM | 70.04% |
OM growth 3Y0.02%
OM growth 5Y3.47%
PM growth 3Y-6.53%
PM growth 5Y12.13%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
1SAN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for 1SAN has been reduced compared to 1 year ago.
1SAN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 1SAN has been reduced compared to a year ago.
2.2 Solvency
1SAN has a debt to FCF ratio of 3.04. This is a good value and a sign of high solvency as 1SAN would need 3.04 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.04, 1SAN is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
1SAN has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of 1SAN (0.17) is better than 68.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 3.04 | ||
| Altman-Z | N/A |
ROIC/WACC2.03
WACC7.67%
2.3 Liquidity
1SAN has a Current Ratio of 1.46. This is a normal value and indicates that 1SAN is financially healthy and should not expect problems in meeting its short term obligations.
1SAN has a Current ratio of 1.46. This is comparable to the rest of the industry: 1SAN outperforms 56.86% of its industry peers.
1SAN has a Quick Ratio of 1.46. This is a bad value and indicates that 1SAN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of 1SAN (0.74) is worse than 76.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.46 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
1SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.30%.
The Earnings Per Share has been growing slightly by 5.10% on average over the past years.
Looking at the last year, 1SAN shows a very strong growth in Revenue. The Revenue has grown by 31.50%.
The Revenue has been growing slightly by 3.31% on average over the past years.
EPS 1Y (TTM)-5.3%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-21.08%
Revenue 1Y (TTM)31.5%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-3.25%
3.2 Future
Based on estimates for the next years, 1SAN will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.23% on average per year.
Based on estimates for the next years, 1SAN will show a small growth in Revenue. The Revenue will grow by 4.33% on average per year.
EPS Next Y8.37%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
EPS Next 5Y8.23%
Revenue Next Year4.99%
Revenue Next 2Y5.79%
Revenue Next 3Y5.48%
Revenue Next 5Y4.33%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.19 indicates a correct valuation of 1SAN.
Based on the Price/Earnings ratio, 1SAN is valued a bit cheaper than the industry average as 74.51% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.78. 1SAN is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 11.25, which indicates a very decent valuation of 1SAN.
Based on the Price/Forward Earnings ratio, 1SAN is valued a bit cheaper than the industry average as 72.55% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, 1SAN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.19 | ||
| Fwd PE | 11.25 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1SAN is on the same level as its industry peers.
1SAN's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.93 | ||
| EV/EBITDA | 10.03 |
4.3 Compensation for Growth
1SAN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.46
PEG (5Y)2.39
EPS Next 2Y9.02%
EPS Next 3Y8.18%
5. Dividend
5.1 Amount
1SAN has a Yearly Dividend Yield of 4.32%, which is a nice return.
1SAN's Dividend Yield is rather good when compared to the industry average which is at 3.13. 1SAN pays more dividend than 82.35% of the companies in the same industry.
1SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.32% |
5.2 History
The dividend of 1SAN has a limited annual growth rate of 4.34%.
Dividend Growth(5Y)4.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
39.72% of the earnings are spent on dividend by 1SAN. This is a low number and sustainable payout ratio.
The dividend of 1SAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP39.72%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
BIT:1SAN (4/23/2025, 7:00:00 PM)
93.6
+2.85 (+3.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners39.32%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap229.14B
Analysts80.69
Price Target117.77 (25.82%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.32% |
Yearly Dividend3.79
Dividend Growth(5Y)4.34%
DP39.72%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.16%
Min EPS beat(2)-2.18%
Max EPS beat(2)14.5%
EPS beat(4)3
Avg EPS beat(4)4.59%
Min EPS beat(4)-2.18%
Max EPS beat(4)14.5%
EPS beat(8)5
Avg EPS beat(8)2.9%
EPS beat(12)8
Avg EPS beat(12)3.44%
EPS beat(16)12
Avg EPS beat(16)4.38%
Revenue beat(2)1
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-4.57%
Max Revenue beat(2)3.66%
Revenue beat(4)2
Avg Revenue beat(4)0.11%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)3
Avg Revenue beat(8)-0.73%
Revenue beat(12)7
Avg Revenue beat(12)19.67%
Revenue beat(16)11
Avg Revenue beat(16)28.47%
PT rev (1m)-0.56%
PT rev (3m)3.6%
EPS NQ rev (1m)-1.72%
EPS NQ rev (3m)-11.55%
EPS NY rev (1m)0.2%
EPS NY rev (3m)-4.47%
Revenue NQ rev (1m)0.37%
Revenue NQ rev (3m)-9.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.19 | ||
| Fwd PE | 11.25 | ||
| P/S | 2.49 | ||
| P/FCF | 38.93 | ||
| P/OCF | 25.23 | ||
| P/B | 2.95 | ||
| P/tB | 20.03 | ||
| EV/EBITDA | 10.03 |
EPS(TTM)7.68
EY8.21%
EPS(NY)8.32
Fwd EY8.89%
FCF(TTM)2.4
FCFY2.57%
OCF(TTM)3.71
OCFY3.96%
SpS37.6
BVpS31.74
TBVpS4.67
PEG (NY)1.46
PEG (5Y)2.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9% | ||
| ROE | 15.37% | ||
| ROCE | 19.55% | ||
| ROIC | 15.58% | ||
| ROICexc | 16.79% | ||
| ROICexgc | 53.71% | ||
| OM | 22.04% | ||
| PM (TTM) | 12.97% | ||
| GM | 70.04% | ||
| FCFM | 6.39% |
ROA(3y)5.07%
ROA(5y)6.23%
ROE(3y)8.63%
ROE(5y)10.88%
ROIC(3y)7.46%
ROIC(5y)7.05%
ROICexc(3y)8.27%
ROICexc(5y)7.94%
ROICexgc(3y)35.84%
ROICexgc(5y)35.27%
ROCE(3y)9.37%
ROCE(5y)8.86%
ROICexcg growth 3Y-11.4%
ROICexcg growth 5Y0.08%
ROICexc growth 3Y1.08%
ROICexc growth 5Y3.67%
OM growth 3Y0.02%
OM growth 5Y3.47%
PM growth 3Y-6.53%
PM growth 5Y12.13%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 3.04 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 89.1% | ||
| Cap/Sales | 3.47% | ||
| Interest Coverage | -34.57 | ||
| Cash Conversion | 38.03% | ||
| Profit Quality | 49.3% | ||
| Current Ratio | 1.46 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | N/A |
F-Score7
WACC7.67%
ROIC/WACC2.03
Cap/Depr(3y)72.19%
Cap/Depr(5y)66.85%
Cap/Sales(3y)6.19%
Cap/Sales(5y)5.87%
Profit Quality(3y)111.96%
Profit Quality(5y)103.11%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.3%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-21.08%
EPS Next Y8.37%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
EPS Next 5Y8.23%
Revenue 1Y (TTM)31.5%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-3.25%
Revenue Next Year4.99%
Revenue Next 2Y5.79%
Revenue Next 3Y5.48%
Revenue Next 5Y4.33%
EBIT growth 1Y21.75%
EBIT growth 3Y4.19%
EBIT growth 5Y6.9%
EBIT Next Year37.04%
EBIT Next 3Y15.5%
EBIT Next 5Y10.86%
FCF growth 1Y-18.63%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y-11.47%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%